| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11018591 | HPB | 2018 | 11 Pages |
Abstract
Methodological and statistical heterogeneity precluded consensus on the optimal treatment strategy. Given the common use and significant cost of radioembolization in this setting, a more robust prospective comparative trial is warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Jordan Levy, Jesse Zuckerman, Richard Garfinkle, Sergio A. Acuna, Jacynthe Touchette, Tsafrir Vanounou, Jean-Sebastien Pelletier,